Search

Search Constraints

You searched for: Author/Creator Busque, Lambert

Search Results

2. Molecular monitoring of therapeutic milestones and clinical outcomes in patients with chronic myeloid leukemia. Issue 4 (13th November 2018)

3. Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis. (28th May 2019)

4. The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia. (January 2020)

5. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Issue 8 (August 2021)

6. The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study. Issue 8 (3rd July 2021)

8. BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase. (8th September 2021)

10. Natural spring water gargle samples as an alternative to nasopharyngeal swabs for SARS‐CoV‐2 detection using a laboratory‐developed test. Issue 3 (3rd November 2021)